Skip to content

West Virginia Medicaid

Does West Virginia Medicaid cover Mounjaro for Type 2 Diabetes?

Yes. West Virginia Medicaid covers Mounjaro for type 2 diabetes with prior authorization. Other policy requirements and your plan's benefits also apply.

Policy document

  • West Virginia Medicaid Medicaid prior authorization policy

    West Virginia Medicaid · PA policy · Medicaid

    Effective January 1, 2026. Verified June 3, 2026.

    View PDF Download Original insurer source
  • Medicaid: Covered with requirements. See the qualification pathways below.

Earliest policy review June 3, 2026. How we verify · Check your exact plan

Full requirements: Mounjaro for Type 2 Diabetes (1 plan type)

Applies to Medicaid plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Non-preferred GLP-1 agonist — all criteria must be met

All of:

  • Diagnosis of Diabetes Mellitus Type II
  • Current A1C submitted and A1C ≥ 7%
  • Documentation of 90 days of compliance on all current diabetic therapies
  • Documentation of treatment failure with ALL unique preferred agents in the GLP-1 class (Ozempic, Trulicity, and Victoza)

Documentation to bring

  • Documentation of Diabetes Mellitus Type II diagnosis
  • Current A1C lab result (must be ≥ 7%)
  • Documentation demonstrating 90 days of compliance on all current diabetic therapies
  • Documentation of treatment failure with all preferred GLP-1 agents (Ozempic, Trulicity, Victoza)

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • Renewal: Improvement in A1C.
  • Renewal: Re-authorization requires documentation of continued compliance on all diabetic therapies AND A1C must reach goal (A1C ≤ 8% OR demonstrated continued improvement).

Not covered when

  • GLP-1 agents will NOT be approved in combination with a DPP-4 inhibitor
  • Type 1 diabetes

Policy note: Mounjaro (tirzepatide) is listed as a NON-PREFERRED agent in the GLP-1 Agonists class. Approvals are in 6-month intervals. Requires treatment failure with ALL three preferred agents: Ozempic, Trulicity, and Victoza. The class note explicitly prohibits concurrent use with a DPP-4 inhibitor.

Policy effective January 1, 2026 · verified June 3, 2026 · source: West Virginia Medicaid Medicaid prior authorization policy · View policy document (PDF)

Open on its own page →

Questions people ask
Does West Virginia Medicaid cover Mounjaro?
Yes. West Virginia Medicaid covers Mounjaro for type 2 diabetes with prior authorization. Other policy requirements and your plan's benefits also apply.
How long does a Mounjaro approval last with West Virginia Medicaid?
Type 2 Diabetes — Applies to Medicaid plans. Initial approval: 6 months. Renewal: every 6 months.
What does West Virginia Medicaid require to renew Mounjaro?
Type 2 Diabetes — Applies to Medicaid plans. Improvement in A1C. Re-authorization requires documentation of continued compliance on all diabetic therapies AND A1C must reach goal (A1C ≤ 8% OR demonstrated continued improvement).
How current is this information?
The oldest review date among the policies on this page is June 3, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under West Virginia Medicaid: Ozempic, Wegovy, Zepbound

Mounjaro under other plans: Alabama Medicaid, Arkansas Medicaid, California Medicaid, Colorado Medicaid, Connecticut Medicaid, Delaware Medicaid, Florida Medicaid, Georgia Medicaid

All insurance plans · All medications

Summary of West Virginia Medicaid's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.